These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 25593242

  • 1. Safety and efficacy of rituximab in childhood-onset systemic lupus erythematosus and other rheumatic diseases.
    Tambralli A, Beukelman T, Cron RQ, Stoll ML.
    J Rheumatol; 2015 Mar; 42(3):541-6. PubMed ID: 25593242
    [Abstract] [Full Text] [Related]

  • 2. Rituximab therapy has a rapid and durable response for refractory cytopenia in childhood-onset systemic lupus erythematosus.
    Olfat M, Silverman ED, Levy DM.
    Lupus; 2015 Aug; 24(9):966-72. PubMed ID: 25804672
    [Abstract] [Full Text] [Related]

  • 3. Anti CD20 (Rituximab) therapy in refractory pediatric rheumatic diseases.
    Reis J, Aguiar F, Brito I.
    Acta Reumatol Port; 2016 Aug; 41(1):45-55. PubMed ID: 27115107
    [Abstract] [Full Text] [Related]

  • 4. Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases.
    Gottenberg JE, Guillevin L, Lambotte O, Combe B, Allanore Y, Cantagrel A, Larroche C, Soubrier M, Bouillet L, Dougados M, Fain O, Farge D, Kyndt X, Lortholary O, Masson C, Moura B, Remy P, Thomas T, Wendling D, Anaya JM, Sibilia J, Mariette X, Club Rheumatismes et Inflammation (CRI).
    Ann Rheum Dis; 2005 Jun; 64(6):913-20. PubMed ID: 15550531
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness and Safety of Rituximab in Systemic Lupus Erythematosus: A Case Series Describing the Experience of 2 Centers.
    Gómez VJ, Carrión-Barberá I, Salman Monte TC, Acosta A, Torrente-Segarra V, Monfort J.
    Reumatol Clin (Engl Ed); 2020 Jun; 16(5 Pt 2):391-395. PubMed ID: 30522941
    [Abstract] [Full Text] [Related]

  • 6. Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French AutoImmunity and Rituximab registry.
    Terrier B, Amoura Z, Ravaud P, Hachulla E, Jouenne R, Combe B, Bonnet C, Cacoub P, Cantagrel A, de Bandt M, Fain O, Fautrel B, Gaudin P, Godeau B, Harlé JR, Hot A, Kahn JE, Lambotte O, Larroche C, Léone J, Meyer O, Pallot-Prades B, Pertuiset E, Quartier P, Schaerverbeke T, Sibilia J, Somogyi A, Soubrier M, Vignon E, Bader-Meunier B, Mariette X, Gottenberg JE, Club Rhumatismes et Inflammation.
    Arthritis Rheum; 2010 Aug; 62(8):2458-66. PubMed ID: 20506527
    [Abstract] [Full Text] [Related]

  • 7. Rituximab use in pediatric systemic lupus erythematosus: Indications, efficacy and safety in an Indian cohort.
    Sawhney S, Agarwal M.
    Lupus; 2021 Oct; 30(11):1829-1836. PubMed ID: 34315295
    [Abstract] [Full Text] [Related]

  • 8. Pediatric systemic lupus erythematosus in Thammasat University Hospital.
    Pusongchai T, Jungthirapanich J, Khositseth S.
    J Med Assoc Thai; 2010 Dec; 93 Suppl 7():S283-93. PubMed ID: 21294427
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and Safety of Rituximab in Systemic Lupus Erythematosus and Sjögren Syndrome Patients With Refractory Thrombocytopenia: A Retrospective Study of 21 Cases.
    Jiang B, Li T, Guo L, Shen H, Ye S, Chen S.
    J Clin Rheumatol; 2015 Aug; 21(5):244-50. PubMed ID: 26203828
    [Abstract] [Full Text] [Related]

  • 10. Predicting Severe Infection and Effects of Hypogammaglobulinemia During Therapy With Rituximab in Rheumatic and Musculoskeletal Diseases.
    Md Yusof MY, Vital EM, McElvenny DM, Hensor EMA, Das S, Dass S, Rawstron AC, Buch MH, Emery P, Savic S.
    Arthritis Rheumatol; 2019 Nov; 71(11):1812-1823. PubMed ID: 31131994
    [Abstract] [Full Text] [Related]

  • 11. Current role of rituximab in systemic lupus erythematosus.
    Mok CC.
    Int J Rheum Dis; 2015 Feb; 18(2):154-63. PubMed ID: 25522652
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of rituximab for systemic lupus erythematosus-associated immune cytopenias: A multicenter retrospective cohort study of 71 adults.
    Serris A, Amoura Z, Canouï-Poitrine F, Terrier B, Hachulla E, Costedoat-Chalumeau N, Papo T, Lambotte O, Saadoun D, Hié M, Blanche P, Lioger B, Gottenberg JE, Godeau B, Michel M.
    Am J Hematol; 2018 Mar; 93(3):424-429. PubMed ID: 29247540
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and Safety of Rituximab in the Management of Pediatric Systemic Lupus Erythematosus: A Systematic Review.
    Mahmoud I, Jellouli M, Boukhris I, Charfi R, Ben Tekaya A, Saidane O, Ferjani M, Hammi Y, Trabelsi S, Khalfallah N, Tekaya R, Gargah T, Abdelmoula L.
    J Pediatr; 2017 Aug; 187():213-219.e2. PubMed ID: 28602379
    [Abstract] [Full Text] [Related]

  • 14. Rituximab infusion-related adverse event rates are lower in patients with systemic lupus erythematosus than in those with rheumatoid arthritis.
    Conti F, Ceccarelli F, Perricone C, Alessandri C, Conti V, Massaro L, Truglia S, Spinelli FR, Spadaro A, Valesini G.
    Rheumatology (Oxford); 2011 Jun; 50(6):1148-52. PubMed ID: 21278072
    [Abstract] [Full Text] [Related]

  • 15. Use of Rituximab in Systemic Lupus Erythematosus: A Single Center Experience Over 14 Years.
    Aguiar R, Araújo C, Martins-Coelho G, Isenberg D.
    Arthritis Care Res (Hoboken); 2017 Feb; 69(2):257-262. PubMed ID: 27110698
    [Abstract] [Full Text] [Related]

  • 16. Rituximab therapy for childhood-onset systemic lupus erythematosus.
    Willems M, Haddad E, Niaudet P, Koné-Paut I, Bensman A, Cochat P, Deschênes G, Fakhouri F, Leblanc T, Llanas B, Loirat C, Pillet P, Ranchin B, Salomon R, Ulinski T, Bader-Meunier B, French Pediatric-Onset SLE Study Group.
    J Pediatr; 2006 May; 148(5):623-627. PubMed ID: 16737873
    [Abstract] [Full Text] [Related]

  • 17. Rituximab in Treatment of Children with Refractory Vasculitis and Systemic Lupus Erythematosus - Single Center Experience in Croatia.
    Sršen S, Frković M, Malčić I, Jelušić M.
    Acta Dermatovenerol Croat; 2020 Aug; 28(2):63-69. PubMed ID: 32876030
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of anti-CD20 antibody rituximab for patients with refractory systemic lupus erythematosus.
    Iwata S, Saito K, Hirata S, Ohkubo N, Nakayamada S, Nakano K, Hanami K, Kubo S, Miyagawa I, Yoshikawa M, Miyazaki Y, Yoshinari H, Tanaka Y.
    Lupus; 2018 Apr; 27(5):802-811. PubMed ID: 29308726
    [Abstract] [Full Text] [Related]

  • 19. Safety and efficacy of rituximab in refractory pediatric systemic lupus erythematosus nephritis: a single-center experience of Northern Greece.
    Trachana M, Koutsonikoli A, Farmaki E, Printza N, Tzimouli V, Papachristou F.
    Rheumatol Int; 2013 Mar; 33(3):809-13. PubMed ID: 22101555
    [Abstract] [Full Text] [Related]

  • 20. Methotrexate therapy in refractory pediatric onset systemic lupus erythematosus.
    Ravelli A, Ballardini G, Viola S, Villa I, Ruperto N, Martini A.
    J Rheumatol; 1998 Mar; 25(3):572-5. PubMed ID: 9517783
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.